Related Experiment Video
Updated: Feb 14, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
IL-36 cytokines in autoimmunity and inflammatory disease
Liping Ding1, Xiaohui Wang2, Xiaoping Hong1
1Department of Rheumatology and Immunology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, China.
Interleukin-36 (IL-36) cytokines are key players in inflammation. This review explores IL-36 activation and its role in autoimmune and inflammatory diseases, offering insights into their pathophysiology.
Area of Science:
- Immunology
- Cytokine Biology
- Inflammation Research
Background:
- Interleukin-36 (IL-36) cytokines (IL-36α, IL-36β, IL-36γ, IL-36Ra) are part of the IL-1 family.
- These cytokines exhibit pro-inflammatory effects on diverse cell types, including keratinocytes, synoviocytes, dendritic cells, and T cells.
- Growing evidence implicates IL-36 in the pathogenesis of numerous inflammatory conditions.
Purpose of the Study:
- To review the activation mechanisms of IL-36 family cytokines.
- To examine the involvement of IL-36 in autoimmune and inflammatory diseases.
- To enhance understanding of IL-36 functions in disease pathophysiology.
Main Methods:
- Literature review of scientific publications.
- Synthesis of current knowledge on IL-36 cytokine activation.
- Analysis of IL-36 roles in various inflammatory and autoimmune disease models.
Main Results:
- IL-36 cytokines are activated through specific pathways.
- IL-36 signaling contributes significantly to the development and progression of inflammatory diseases.
- Dysregulation of IL-36 is linked to autoimmune conditions.
Conclusions:
- IL-36 cytokines are critical mediators in inflammatory and autoimmune diseases.
- Understanding IL-36 activation and function is vital for therapeutic strategies.
- Further research into IL-36 pathways may reveal novel treatment targets.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

